Skip to content

Tarsus Pharmaceuticals, Inc. TARS Operating lease liability

Operating lease liability at other companies

1st Source Corporation logo
1st Source CorporationSRCE
$3.99M-8.7%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$15.92M+160%
Bank of Hawaii logo
Bank of HawaiiBOH
$24.49M+4.1%
Encore Capital Group logo
Encore Capital GroupECPG
$10.52M-8.7%
TPG Inc. logo
TPG Inc.TPG
$5.28M+150%
MYR Group logo
MYR GroupMYRG
$50.35M+18.9%

Other financials

Income statement

See full
Revenue$162.1M+107%
Gross profit$152.7M+109%
Operating income-$6.1M+76.7%
Net income-$7.0M+72.3%
EPS (diluted)-$0.16+75.0%

Balance sheet

See full
Cash & equivalents$104.2M-41.6%
Total debt$88.7M+22.5%
Total equity$349.0M+1.9%
Total assets$581.1M+16.1%

Cash flow

See full
Operating cash flow-$24.7M-19.4%
CapEx$5.8M+886%
Free cash flow-$30.5M-43.4%

Valuation

See full
Market cap$2.85B+41.1%
Enterprise value$2.83B+47.8%
P/S5.3×-3.3×

Profitability

See full
Gross margin42.7%
Operating margin-9.5%-4.2pp
Net margin-9%-4.0pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-14%-5.2pp
Debt / equity0.3×0.0×
Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept tars:DeferredTaxAssetsOperatingLeaseLiability.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s operating lease liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s operating lease liability?
Tarsus Pharmaceuticals, Inc. (TARS) reported operating lease liability of $4.36M in Q4 2025.
What does operating lease liability mean?
This represents the total present value of future lease payments for operating assets, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased facilities and equipment necessary for operations. Monitoring this liability is essential for evaluating the company's fixed cost structure and overall financial leverage.